fatty acid oxidation raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-05-11 and is reviewed periodically as new material appears.
Activation of PPARδ changes transcription of genes involved in fatty acid transport, mitochondrial function, and skeletal muscle fuel preference. In rodent studies, pharmacological PPARδ activation was associated with increased endurance and altered body composition. These findings generated interest in performance enhancement, but species differences and study designs limit direct extrapolation to humans. Small human trials were conducted in the 2000s and later discontinued. The extent to which cardarine produces similar metabolic or performance effects in people remains an open question.
The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.
Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.
Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.
Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.
Regulatory treatment of cardarine differs by context and jurisdiction. In competitive sport, the World Anti-Doping Agency lists PPARδ agonists, including GW501516, as prohibited at all times. Outside sport, it lacks approval as a prescription medicine in major drug markets, and products sold for human consumption may be treated as unapproved drugs. Some countries also restrict importation or sale through general consumer protection and medicines laws. These classifications affect availability, testing, and legal risk without establishing therapeutic value.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic PPARδ agonist | Not a steroid or a selective androgen receptor modulator. |
| Common synonyms | Cardarine, GW501516, GW-501516, endurobol | Names vary by supplier and literature source. |
| Appearance | White to off-white powder | Consistent with many small-molecule research chemicals. |
| Solubility | Low in water; soluble in DMSO and ethanol | Often prepared in organic solvent for laboratory work. |
| Primary target | PPARδ (NR1C2) | Nuclear receptor involved in lipid and energy metabolism. |
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
== Sources == This article incorporates text from a free content work. Licensed under Creative Commons Attribution (license statement/permission). Text taken from Late Professor P N Saxena: A teacher of excellence, Rahman, SZ; Khan, RA (Nov 2010), J Pharmacol Pharmacother.
== History == The Panda Restaurant Group, parent company of Panda Inn, Panda Express, and Hibachi-San, was founded by Andrew Cherng, Peggy Cherng and Andrew's father, Master Chef Ming Tsai Cherng. Andrew Cherng and his father are Chinese born, while Peggy was born in Burma and raised in Hong Kong. Both Andrew and Peggy Cherng are alumni of Baker University in Baldwin City, Kansas (where they first met).
== Selected awards == US National Academy of Inventors, Elected Fellow, 2018 T. & A. Higuchi Memorial Lectureship Award, Academy of Pharmaceutical Science and Technology, Japan, 2018 Distinguished Mentor Award, University of Utah, 2017 Doctor of Philosophy honoris causa, University of Helsinki, Finland, 2014 US National Academy of Engineering, Member, 2011 Honorary professorship, Sichuan University, China, 2007 Distinguished International Scientist Award, Japanese Biomaterials Society, 2006 Chair, Gordon Research Conference on Drug Carriers in Medicine and Biology, 2004 J. Heyrovský Honorary Medal for Merit in the Chemical Sciences, Academy of Sciences of the Czech Republic, 2003 Paul Dawson Biotechnology Award, American Association of Colleges of Pharmacy, 2001 Millennial Pharmaceutical Scientist Award, Millennial World Congress of Pharm. Sciences, 2000 Fellow of Biomaterials Science and Engineering, International Union of Societies of Biomaterials Science and Engineering, 1999 Founders Award, Controlled Release Society, 1999 Czech Learned Society, Honorary Member, 1998 Award of the Presidia of the Czechoslovak and USSR Academies of Sciences 1977 Selected publications and patents
=== Scientific === Radon emanation from the soil varies with soil type and with surface uranium content, so outdoor radon concentrations can be used to track air masses to a limited degree. Because of radon's rapid loss to air and comparatively rapid decay, radon is used in hydrologic research that studies the interaction between groundwater and streams. Any significant concentration of radon in a river may be an indicator that there are local inputs of groundwater. Radon soil concentration has been used to map buried close-subsurface geological faults because concentrations are generally higher over the faults. Similarly, it has found some limited use in prospecting for geothermal gradients. Some researchers have investigated changes in groundwater radon concentrations for earthquake prediction. Increases in radon were noted before the 1966 Tashkent and 1994 Mindoro earthquakes. Radon has a half-life of approximately 3.8 days, which means that it can be found only shortly after it has been produced in the radioactive decay chain. For this reason, it has been hypothesized that increases in radon concentration is due to the generation of new cracks underground, which would allow increased groundwater circulation, flushing out radon. The generation of new cracks might not unreasonably be assumed to precede major earthquakes. In the 1970s and 1980s, scientific measurements of radon emissions near faults found that earthquakes often occurred with no radon signal, and radon was often detected with no earthquake to follow.
=== Pulse experiments === This method required the introduction of a very small volume of concentrated tracer at the inlet of the reactor, such that it approaches the Dirac delta function. Although an infinitely short injection cannot be produced, it can be made much smaller than the mean residence time of the vessel. If a mass of tracer,
Sources: en.wikipedia.org
David Renton (born 1972), author and barrister, was member of the Socialist Workers Party (SWP); has published books on fascism, anti-fascism and politics of left, notably Labour's Antisemitism Crisis: What the Left Got Wrong and How to Learn from it (Routledge, 2021) on presumed anti-Semitism in the British Labour Party; has also written for The Jewish Chronicle; Renton is grandson of shoe designer Kurt Geiger of Viennese Jewish ancestry, and related to Conservative MP Tim Renton, Baron Renton of Mount Harry; David Renton was educated at private boarding school Eton College where he became member of Labour Party; later studied history at St John's College, University of Oxford; in 2021, Renton represented Stan Keable of Labour Against the Witchhunt, at Employment Appeal Tribunal, which held that Keable was unfairly dismissed for events occurring at the "Enough is Enough" protests against Jeremy Corbyn. The EAT upheld an order that Keable should be reinstated. Dave Rich, Head of Policy at the Community Security Trust writes on what is perceived to be British left-wing antisemitism. He is an associate research fellow at the Pears Institute for the Study of Antisemitism. Rich has written a book, published in 2016, The Left's Jewish Problem: Jeremy Corbyn, Israel and Anti‑Semitism which began as his doctoral dissertation. Claudia Roden (born 1936), Egyptian-born cookery book writer and cultural anthropologist.
=== Blood banking === Blood banking is a concentration within a clinical laboratory that analyzes specimens from potential transfusion recipients and provides compatible blood products to the healthcare team in charge of that patient's care. Several routine tests are performed including blood typing (determination of ABO/Rh status), antibody screening, serologic cross-matching, direct antiglobulin testing, and antibody identification. Beyond the presence of naturally occurring antibodies (isohemagglutinins) to the ABO and Rh(D) blood group antigens, additional immune-stimulated antibodies are considered unexpected alloantibodies. The identification of unexpected antibodies is a labor-intensive process, and sometimes requires the addition of special laboratory techniques to aid in the proper identification of the antibody. Among these techniques are elutions, adsorptions, and enzyme treatment. Some patients produce antibodies to high frequency antigens. That is, the red cell antigens are present in a significant portion of the human population. It may be questionable and very difficult to assess if the antibody is considered clinically significant or not. A clinically significant antibody is an antibody that is capable of causing in vitro hemolysis or a decreased survival of transfused donor red blood cells. Antibodies to high frequency antigens can be assessed for clinical significance using the monocyte monolayer assay.
== History == Dextromoramide was discovered and patented in 1956 by Paul Janssen at Janssen Pharmaceuticals, who also discovered fentanyl, another important synthetic opioid, widely used to treat pain and in combination with other drugs as an anaesthetic, as well as haloperidol, piritramide, the loperamide-diphenoxylate series and other important drugs. Dextromoramide was much favoured by drug users in Australia in the 1970s and the United Kingdom. It has the main proprietary name of Palfium amongst others, though as of mid-2004 the drug was discontinued in the UK due to limited supplies of precursor chemicals. Although this is true, it is believed there was an approximate one year shortage of Dextromoramide and the real reason that Palfium was not put back into production for the UK market is because of how addictive and potent it is as an oral painkiller. Dependence liability is similar to morphine, but with a less severe withdrawal syndrome. The only European countries that now use the brand Palfium are the Netherlands, Ireland and Luxembourg. It is presumably able to be imported into other Schengen zone countries under Title 76 of said treaty coming into force in 2002. It is a Schedule I Narcotic controlled substance in the United States, with a DEA ACSCN of 9613 and an annual aggregate manufacturing quota of zero as of 2013, and had been out of use in the United States for around a decade when the new Controlled Substances Act 1970 was promulgated. The salts of dextromoramide in use are the hydrochloride (free base conversion ratio 0.915) and tartrate (0.724).
== History == Vaccine storage was first developed in the early 1960s, when the infectious smallpox disease outbreaks. During this time, vaccine technology was available and offered for protection. Since smallpox has been one of the deadliest diseases known, the World Health Organization (WHO) prepared to launch a campaign to spread the vaccines and end smallpox in 1966. It was not until 1974 where WHO first introduced the Expanded Programme on Immunization (EPI). The main goal was to make immunization available to every child worldwide by 1990. Immunization of six illnesses was being transported, including tuberculosis, diphtheria, pertussis, tetanus, measles, and polio. Dr. Rafe Henderson, the first director of EPI, designed a plan to deliver temperature-sensitive vaccines across dozens of countries safely. It was an important step to ensure that the vaccines were maintained in their determined conditions and guides towards the development of the cold chain. The WHO supported countries worldwide to ensure the vaccine cold chain is maintained. The cold chain has been implemented for years. After EPI was initiated, over 700,000 measles deaths were prevented, and millions of the target diseases have been prevented. There has been a huge milestone in the vaccine industry as scientists create more vaccines for new types of diseases. Therefore, it has a direct impact on the cost of transportation and different kinds of refrigerator storage either at +2° to +8 °C or +20° to +25 °C.
Due to the reduced water content of the freeze-dried foods that inhibit the growth of microorganisms and prevent enzymatic chemical reactions, these foods are considered shelf-stable and can be kept safe from spoilage for years by preventing the reabsorption of moisture. Freeze-dried foods can be stored at room temperature without the need for refrigeration. Although uncommon compared to most applications, sometimes a seasoning solution is sprayed directly onto ramen noodles to enhance their flavor, prior to being packaged. Powder seasoning packets may also contain anticaking agents and flow agents to prevent the product from clumping into a solid mass.
Sources: en.wikipedia.org
Cardarine is a common name for GW501516, a synthetic PPARδ agonist. It is not a steroid or a selective androgen receptor modulator. It was developed and studied as a research compound for metabolic pathways.
It binds to and activates PPARδ, a nuclear receptor that regulates genes related to fatty acid oxidation and energy use. This activation alters transcription in tissues such as skeletal muscle and liver. The full range of downstream effects in humans is not fully established.
No, cardarine is not known to occur naturally in plants, animals, or humans. It is a synthetic molecule produced for laboratory research. Products labeled as cardarine should therefore be treated as manufactured chemicals with variable purity.
Anti-doping laboratories typically use LC-MS/MS to detect GW501516 and its metabolites in urine. The method is sensitive and can identify the compound at low concentrations. Detection depends on sample timing, metabolism, and the specific assay.